CN101754764A - 治疗小儿性腺机能减退的组合物和方法 - Google Patents

治疗小儿性腺机能减退的组合物和方法 Download PDF

Info

Publication number
CN101754764A
CN101754764A CN200880009284A CN200880009284A CN101754764A CN 101754764 A CN101754764 A CN 101754764A CN 200880009284 A CN200880009284 A CN 200880009284A CN 200880009284 A CN200880009284 A CN 200880009284A CN 101754764 A CN101754764 A CN 101754764A
Authority
CN
China
Prior art keywords
testosterone
use according
treatment
age
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880009284A
Other languages
English (en)
Chinese (zh)
Inventor
罗伯特·E·达德利
艾伦·D·罗戈尔
珍妮特·贝尼什
特洛伊·L·祖姆布鲁嫩
格雷格·普拉特
约翰·J·布伦南
亚尔马·拉加斯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Besins International SAS
Unimed Pharmaceuticals LLC
Original Assignee
Laboratoires Besins International SAS
Unimed Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Besins International SAS, Unimed Pharmaceuticals LLC filed Critical Laboratoires Besins International SAS
Publication of CN101754764A publication Critical patent/CN101754764A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200880009284A 2007-03-23 2008-03-20 治疗小儿性腺机能减退的组合物和方法 Pending CN101754764A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07104726.0 2007-03-23
EP07104726 2007-03-23
PCT/EP2008/053372 WO2008116825A2 (en) 2007-03-23 2008-03-20 Compositions and method for treating pediatric hypogonadism

Publications (1)

Publication Number Publication Date
CN101754764A true CN101754764A (zh) 2010-06-23

Family

ID=38321980

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880009284A Pending CN101754764A (zh) 2007-03-23 2008-03-20 治疗小儿性腺机能减退的组合物和方法

Country Status (10)

Country Link
EP (1) EP2136813A2 (enExample)
JP (1) JP2010521519A (enExample)
CN (1) CN101754764A (enExample)
AU (1) AU2008231781B2 (enExample)
BR (1) BRPI0809124A8 (enExample)
CA (1) CA2623477C (enExample)
EA (1) EA018775B1 (enExample)
IL (1) IL200887A0 (enExample)
MX (1) MX2009008995A (enExample)
WO (1) WO2008116825A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3755B1 (ar) * 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
JP6152092B2 (ja) * 2011-05-15 2017-06-28 エーセラス ファーマシューティカルズ コーポレーション 経鼻投与のための徐放テストステロン鼻腔内ゲル、方法および複数回用量プレフィルアプリケーターシステム

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
US7138389B2 (en) * 2004-02-09 2006-11-21 University Of Washington Oral androgen therapy using modulators of testosterone bioavailability
CA2624788C (en) * 2005-10-12 2011-04-19 Unimed Pharmaceuticals, Llc Improved testosterone gel and method of use

Also Published As

Publication number Publication date
MX2009008995A (es) 2009-09-03
AU2008231781B2 (en) 2012-09-20
EP2136813A2 (en) 2009-12-30
IL200887A0 (en) 2010-05-17
EA018775B1 (ru) 2013-10-30
JP2010521519A (ja) 2010-06-24
EA200901288A1 (ru) 2010-04-30
WO2008116825A3 (en) 2008-11-27
AU2008231781A1 (en) 2008-10-02
CA2623477A1 (en) 2008-09-23
CA2623477C (en) 2011-05-31
WO2008116825A2 (en) 2008-10-02
BRPI0809124A2 (pt) 2014-08-26
BRPI0809124A8 (pt) 2015-11-24

Similar Documents

Publication Publication Date Title
JP6012632B2 (ja) テストステロン製剤
US20040002482A1 (en) Androgen pharmaceutical composition and method for treating depression
US20030139384A1 (en) Method for treating erectile dysfunction and increasing libido in men
US20080261937A1 (en) Pharmaceutical compositions and method for treating pediatric hypogonadism
CN105853396A (zh) 透皮或透粘膜应用活性剂的用途和制剂
US20110306582A1 (en) Androgen pharmaceutical composition and method for treating depression
JP2005519985A (ja) 医薬組成物
JP2005515964A (ja) ホルモン欠乏症を治療するための治療用組成物
CN101217874A (zh) 治疗或预防骨退化或骨质疏松症的方法
AU2003228314B2 (en) Androgen pharmaceutical composition and method for treating depression
CN101754764A (zh) 治疗小儿性腺机能减退的组合物和方法
US20070088012A1 (en) Method of treating or preventing type-2 diabetes
CN1997357A (zh) 透皮或透粘膜应用活性剂的用途和制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100623